Skip to search formSkip to main contentSkip to account menu

5 ML galsulfase 1 MG/ML Injection [Naglazyme]

Known as: 5 ML Naglazyme 1 MG/ML Injection, Naglazyme 5 MG per 5 ML Injection, GALSULFASE 5 mg in 5 mL INTRAVENOUS SOLUTION [NAGLAZYME] 
National Institutes of Health

Related topics

Related topics

5 relations
InjectionPolysorbate 80Sodium Chloridegalsulfase

Broader (1)

galsulfase Injection [Naglazyme]

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2017
Review
2017
What does mainstream media say about enzyme replacement therapies?
Introduction Enzyme replacement therapies (ERTs) are expensive drugs that can be used to treat certain inherited diseases. ERTs… 
2010
2010
Galsulfasa (Naglazyme®) per al tractament de la mucopolisacaridosi VI
Mucopolisacaridosi VI; Sindrome de Maroteaux-Lamy; Galsulfasa; Mucopolysaccharidosis type VI; MPS VI; Clinical Trial… 
2008
2008
Development, Validation, and Clinical Implementation of an Assay to Measure Total Antibody Response to Naglazyme® (Galsulfase)
Naglazyme® (galsulfase, rhASB) was developed as enzyme replacement therapy for mucopolysaccharidosis type VI. Naglazyme generated… 
2007
2007
MANIFESTACIONES OSTEOARTICULARES DE LAS ENFERMEDADES POR DEPÓSITO LISOSÓMICO
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)